No Longer Enrolling Archives - MotherToBaby https://mothertobaby.org/category/studies/no-longer-enrolling/ Medications and More during pregnancy and breastfeeding Thu, 01 Feb 2024 23:28:42 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.3 https://mothertobaby.org/wp-content/uploads/2020/10/cropped-MTB-Logo-green-fixed-favicon-32x32.png No Longer Enrolling Archives - MotherToBaby https://mothertobaby.org/category/studies/no-longer-enrolling/ 32 32 Stelara® (ustekinumab) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/stelara/ Mon, 13 Dec 2021 20:40:58 +0000 https://mothertobaby.org/?post_type=ongoing-study&p=5439 This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Stelara® (ustekinumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Stelara® (ustekinumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Orencia® (abatacet) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/orencia/ Mon, 13 Dec 2021 20:39:23 +0000 https://mothertobaby.org/?post_type=ongoing-study&p=5440 This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Orencia® (abatacet) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Orencia® (abatacet) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Ilumya™ (tildrakizumab-asmn) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/ilumya-tildrakizumab-asmn/ Mon, 12 Aug 2019 07:00:00 +0000 http://mothertobaby.org/?ongoing-study=ilumya-tildrakizumab-asmn This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in a study. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Ilumya™ (tildrakizumab-asmn) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in a study. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Ilumya™ (tildrakizumab-asmn) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Fasenra® (benralizumab) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/fasenra-benralizumab/ Wed, 13 Mar 2019 07:00:00 +0000 http://mothertobaby.org/?ongoing-study=fasenra-benralizumab This Study is now closed to recruitment. Thank you for your interest, but unfortunately, we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Fasenra® (benralizumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This Study is now closed to recruitment.

Thank you for your interest, but unfortunately, we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Fasenra® (benralizumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Kevzara® (sarilumab) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/kevzara-sarilumab/ Wed, 16 May 2018 07:00:00 +0000 http://mothertobaby.org/?ongoing-study=kevzara-sarilumab This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in a study. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Kevzara® (sarilumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in a study. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Kevzara® (sarilumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Praluent® (alirocumab) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/praluent-alirocumab/ Fri, 01 Dec 2017 08:00:00 +0000 http://mothertobaby.org/?ongoing-study=praluent-alirocumab This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out our information form by clicking the Make A Difference button below, and a member of our […]

The post Praluent® (alirocumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]>

This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out our information form by clicking the Make A Difference button below, and a member of our team will contact you.

The post Praluent® (alirocumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Actemra® (tocilizumab) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/actemra-tocilizumab/ Wed, 07 Dec 2016 08:00:00 +0000 http://mothertobaby.org/?ongoing-study=actemra-tocilizumab This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Actemra® (tocilizumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Actemra® (tocilizumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Arava® (leflunomide) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/arava-leflunomide/ Wed, 07 Dec 2016 08:00:00 +0000 http://mothertobaby.org/?ongoing-study=arava-leflunomide This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Arava® (leflunomide) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Arava® (leflunomide) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Aubagio® (teriflunomide) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/aubagio-teriflunomide/ Wed, 07 Dec 2016 08:00:00 +0000 http://mothertobaby.org/?ongoing-study=aubagio-teriflunomide This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Aubagio® (teriflunomide) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Aubagio® (teriflunomide) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> Entyvio® (vedolizumab) (NO LONGER ENROLLING) https://mothertobaby.org/ongoing-study/entyvio-vedolizumab/ Wed, 07 Dec 2016 08:00:00 +0000 http://mothertobaby.org/?ongoing-study=entyvio-vedolizumab This study is now closed to recruitment. Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact […]

The post Entyvio® (vedolizumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]> This study is now closed to recruitment.

Thank you for your interest, but unfortunately we are no longer enrolling participants in this study. However, you may be eligible to participate in one of our other ongoing studies. Fill out your information using our Join a Study form, and a member of our team will contact you.

The post Entyvio® (vedolizumab) (NO LONGER ENROLLING) appeared first on MotherToBaby.

]]>